These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 36423387)

  • 21. Evaluation of adverse drug reaction profile of antiepileptic drugs in persons with epilepsy: A cross-sectional study.
    Kumar S; Sarangi SC; Tripathi M; Gupta YK
    Epilepsy Behav; 2020 Apr; 105():106947. PubMed ID: 32109858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Self-reported antiepilepsy medication adherence and its connection to perception of medication error.
    Banks J; Varley J; Fitzsimons M; Doherty CP
    Epilepsy Behav; 2020 Mar; 104(Pt A):106896. PubMed ID: 31986441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recommendations for treatment strategies in people with epilepsy during times of shortage of antiseizure medications.
    Asadi-Pooya AA; Patel AA; Trinka E; Mazurkiewicz-Beldzinska M; Cross JH; Welty TE
    Epileptic Disord; 2022 Oct; 24(5):751-764. PubMed ID: 35894673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trends in the choice of antiseizure medications in juvenile myoclonic epilepsy: A retrospective multi-center study from Turkey between 2010 and 2020.
    Kılıç B; Serdaroğlu E; Polat BG; İnce T; Esenülkü G; Topçu Y; Serdaroğlu A; Haspolat Ş; Tekgül H; Okuyaz Ç; Cansu A; Aydın K
    Seizure; 2022 Jul; 99():48-53. PubMed ID: 35594744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Barriers to generic antiseizure medication use: Results of a global survey by the International League Against Epilepsy Generic Substitution Task Force.
    Niyongere J; Welty TE; Bell MW; Consalvo D; Hammond C; Leung H; Patsalos PN; Ryan M; Suansanae T; Zhou D; Zuellig H
    Epilepsia Open; 2022 Jun; 7(2):260-270. PubMed ID: 35124903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A prospective, multicenter, noninterventional study in Taiwan to evaluate the safety and tolerability of lacosamide as adjunctive therapy for epilepsy in clinical practice.
    Wu T; Chuang YC; Huang HC; Lim SN; Hsieh PF; Lee WT; Cheng MY; Tsai MH; Jou SB; Chang CW; Hsieh HY; Du X; Hellot S; McClung C; Hung C
    Epilepsy Behav; 2020 Dec; 113():107464. PubMed ID: 33152580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of antiseizure medication in post-stroke epilepsy.
    Winter Y; Uphaus T; Sandner K; Klimpe S; Stuckrad-Barre SV; Groppa S
    Seizure; 2022 Aug; 100():109-114. PubMed ID: 35834881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association Between Antiseizure Drug Monotherapy and Mortality for Patients With Poststroke Epilepsy.
    Larsson D; Baftiu A; Johannessen Landmark C; von Euler M; Kumlien E; Åsberg S; Zelano J
    JAMA Neurol; 2022 Feb; 79(2):169-175. PubMed ID: 34902006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of Prenatal Exposure to Antiseizure Medication With Risk of Autism and Intellectual Disability.
    Bjørk MH; Zoega H; Leinonen MK; Cohen JM; Dreier JW; Furu K; Gilhus NE; Gissler M; Hálfdánarson Ó; Igland J; Sun Y; Tomson T; Alvestad S; Christensen J
    JAMA Neurol; 2022 Jul; 79(7):672-681. PubMed ID: 35639399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is the anticonvulsant activity of levetiracetam dose-dependent?
    Lamouret V; Kurth C; Intravooth T; Steinhoff BJ
    Seizure; 2020 Dec; 83():197-202. PubMed ID: 33197757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and tolerability of anti-epileptic drugs-an internet study.
    Wieshmann UC; Baker G
    Acta Neurol Scand; 2017 May; 135(5):533-539. PubMed ID: 27757951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide.
    Hoeltzenbein M; Slimi S; Fietz AK; Stegherr R; Onken M; Beyersmann J; Dathe K; Schaefer C
    Seizure; 2023 Apr; 107():107-113. PubMed ID: 37003184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of psychiatric and behavioral adverse effects of antiepileptic drugs monotherapy: Could they have a neuroendocrine correlation in persons with epilepsy?
    Sarangi SC; Kaur N; Tripathi M
    Epilepsy Behav; 2019 Nov; 100(Pt A):106439. PubMed ID: 31574428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of the coronavirus disease (COVID-19) pandemic on outpatient epilepsy care: An analysis of physician practices in Germany.
    Mueller TM; Kostev K; Gollwitzer S; Lang JD; Stritzelberger J; Westermayer V; Reindl C; Hamer HM
    Epilepsy Behav; 2021 Apr; 117():107833. PubMed ID: 33618316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Affordability, availability and tolerability of anti-seizure medications are better predictors of adherence than beliefs: Changing paradigms from a low resource setting.
    Sunny AA; Iyer RS; Kumaran SG; Bunshaw NG; Shanmugham K; Govindaraj U
    Seizure; 2020 Dec; 83():208-215. PubMed ID: 33227659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential for improved retention rate by personalized antiseizure medication selection: A register-based analysis.
    Håkansson S; Karlander M; Larsson D; Mahamud Z; Garcia-Ptacek S; Zelezniak A; Zelano J
    Epilepsia; 2021 Sep; 62(9):2123-2132. PubMed ID: 34245010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of adjunctive cenobamate based on number of concomitant antiseizure medications, seizure frequency, and epilepsy duration at baseline: A post-hoc analysis of a randomized clinical study.
    Rosenfeld WE; Nisman A; Ferrari L
    Epilepsy Res; 2021 May; 172():106592. PubMed ID: 33662894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiseizure medication adherence trajectories in Medicare beneficiaries with newly treated epilepsy.
    Terman SW; Kerr WT; Marcum ZA; Wang L; Burke JF
    Epilepsia; 2021 Nov; 62(11):2778-2789. PubMed ID: 34462911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The Basis of Medication Therapy for Epilepsy].
    Hanaya R
    No Shinkei Geka; 2023 Jan; 51(1):95-104. PubMed ID: 36682754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in the use of antiseizure medications in children and adolescents in Norway, 2009-2018.
    Heger K; Skipsfjord J; Kiselev Y; Burns ML; Aaberg KM; Johannessen SI; Skurtveit S; Johannessen Landmark C
    Epilepsy Res; 2022 Mar; 181():106872. PubMed ID: 35180640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.